▲ BUY
9
/ 10
Conviction
$ Value
$25K
Shares
29,600
Price
$1
Filed
Feb 13
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 50% (+3)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Aromando Andrew
Title
Chief Business Officer
CIK
0001976455
Roles
Officer
Transaction Details
Transaction Date
2026-02-11
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
55,100
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Filing Info
Aromando Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | ONCY | ▲ | $25K ★ |
Other Insiders at ONCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Seizinger Bernd R. | $83K | — | 2026-02-12 |
|
Kelly Jared
Chief Executive Officer
|
$34K | — | 2026-03-12 |
| Andrews Patricia S | $30K | — | 2026-02-12 |
| Pisano Wayne | $25K | — | 2026-02-12 |
| Brown Deborah Margaret | $21K | — | 2026-02-12 |
| Parsons James T. | $10K | — | 2026-03-11 |
|
Look Kirk
Chief Financial Officer
|
$10K | — | 2026-02-12 |
|
Heineman Thomas Charles
Chief Medical Officer
|
$10K | — | 2026-02-12 |
|
Hagerman Allison
VP, Product Development
|
$8K | — | 2026-02-12 |